| N-cadherin/FGFR promotes metastasis through epithelial-to-mesenchymal transition and stem/progenitor cell-like properties X Qian, A Anzovino, S Kim, K Suyama, J Yao, J Hulit, G Agiostratidou, ... Oncogene 33 (26), 3411-3421, 2014 | 142 | 2014 |
| Purine nucleotide availability regulates mTORC1 activity through the Rheb GTPase N Emmanuel, S Ragunathan, Q Shan, F Wang, A Giannakou, N Huser, ... Cell reports 19 (13), 2665-2680, 2017 | 104 | 2017 |
| Amphiregulin is a critical downstream effector of estrogen signaling in ERα-positive breast cancer EA Peterson, EC Jenkins, KA Lofgren, N Chandiramani, H Liu, E Aranda, ... Cancer research 75 (22), 4830-4838, 2015 | 56 | 2015 |
| Mutant GATA3 actively promotes the growth of normal and malignant mammary cells N Emmanuel, KA Lofgren, EA Peterson, DR Meier, EH Jung, PA Kenny Anticancer research 38 (8), 4435-4441, 2018 | 34 | 2018 |
| Sustained mTORC1 activity during palbociclib-induced growth arrest triggers senescence in ER+ breast cancer cells RS Maskey, F Wang, E Lehman, Y Wang, N Emmanuel, W Zhong, G Jin, ... Cell Cycle 20 (1), 65-80, 2021 | 24 | 2021 |
| VRK1 is a synthetic–lethal target in VRK2-deficient glioblastoma JA Shields, SR Meier, M Bandi, EE Mulkearns-Hubert, N Hajdari, ... Cancer Research 82 (21), 4044-4057, 2022 | 17 | 2022 |
| Molecular basis for vulnerability to mitochondrial and oxidative stress in a neuroendocrine CRI-G1 cell line N Chandiramani, X Wang, M Margeta PLoS One 6 (1), e14485, 2011 | 10 | 2011 |
| VRK1 is a paralog synthetic lethal target in VRK2-methylated glioblastoma JA Shields, SR Meier, M Bandi, MD Ferdinez, JL Engel, ... Biorxiv, 2021.12. 30.474571, 2022 | 2 | 2022 |
| Abstract P2-04-06: Transgenic expression of a breast-cancer specific GATA3 mutant leads to mammary hyperplasia PA Kenny, N Chandiramani Cancer Research 72 (24_Supplement), P2-04-06-P2-04-06, 2012 | 2 | 2012 |
| Comparative analysis of GATA3 mutation profiles between Asian and Western patients with breast cancer: Is there really a difference? N Chandiramani, PA Kenny Cancer (0008543X) 120 (17), 2014 | 1 | 2014 |
| Abstract P182: VRK1 is a novel synthetic lethal target in VRK2-methylated glioblastoma J Shields, SR Meier, J Engel, M Bandi, ML Dam Ferdinez, W Zhang, ... Molecular Cancer Therapeutics 20 (12_Supplement), P182-P182, 2021 | | 2021 |
| Exploring the interplay between the purinosome, a multienzyme, purine biosynthetic machine, and the Rheb-mTORC1 signaling axis. N Emmanuel, E Bernfeld, S Ragunathan, F Wang, Q Shan, A Giannakou, ... MOLECULAR CANCER RESEARCH 18 (10), 34-34, 2020 | | 2020 |
| Abstract A10: Exploring the interplay between the purinosome, a multienzyme, purine biosynthetic machine, and the Rheb-mTORC1 signaling axis N Emmanuel, E Bernfeld, S Ragunathan, F Wang, Q Shan, A Giannakou, ... Molecular Cancer Research 18 (10_Supplement), A10-A10, 2020 | | 2020 |
| SAT-331 Elucidating the Role of Breast Cancer Specific GATA3 Mutation in Estrogen Receptor Positive Breast Cancer K Lofgren, N Emmanuel, D Meier, P Kenny Journal of the Endocrine Society 3 (Supplement_1), SAT-331, 2019 | | 2019 |
| Abstract B025: Purine biosynthesis regulates mTORC1 by modulating Rheb GTPase activity K Unsal-Kacmaz, N Emmanuel, S Ragunathan, Q Shan, F Wang, ... Molecular Cancer Therapeutics 17 (1_Supplement), B025-B025, 2018 | | 2018 |
| Abstract P1-08-02: Mutant GATA3 actively promotes the growth of normal and malignant mammary cells PA Kenny, N Chandiramani, KA Lofgren Cancer Research 77 (4_Supplement), P1-08-02-P1-08-02, 2017 | | 2017 |
| Functional Genomics Approaches to Elucidate the Role of Breast Cancer-Specific Mutations in GATA3 N Chandiramani, P Kenny American Journal of Clinical Pathology 146 (suppl_1), 221, 2016 | | 2016 |
| Mutant GATA3 actively promotes the growth of normal and malignant mammary cells N Chandiramani, E Peterson, PA Kenny Cancer Research 76 (14_Supplement), 1991-1991, 2016 | | 2016 |
| Amphiregulin is a key effector of estrogen receptor in breast cancer EA Peterson, N Chandiramani, EJ Aranda Jaque, EC Jenkins, PA Kenny Cancer Research 75 (15_Supplement), 5046-5046, 2015 | | 2015 |
| Mutant GATA3 drives precocious lobuloalveolar mammary development and promotes the growth of estrogen receptor positive xenograft tumors N Chandiramani, EA Peterson, EH Jung, EC Jenkins, PA Kenny Cancer Research 75 (15_Supplement), 4197-4197, 2015 | | 2015 |
